Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue

World Journal of Gastroenterology

Volumn 12, Issue 37, 2006, Pages 5987-5994

  Massi, Matteo ^a   Ioan, Pierfranco ^a   Budriesi, Roberta ^a   Chiarini, Alberto ^a   Vitali, Beatrice ^a   Lammers, Karen M ^a   Gionchetti, Paolo ^a   Campieri, Massimo ^a   Lembo, Anthony ^b   Brigidi, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Colon; Guinea pigs; Ileum; Intestinal motility; Probiotics

Indexed keywords

BACILLUS LICHENIFORMIS EXTRACT; BIFIDOBACTERIUM BREVE EXTRACT; BIFIDOBACTERIUM INFANTIS EXTRACT; BIFIDOBACTERIUM LONGUM EXTRACT; ESCHERICHIA COLI EXTRACT; LACTOBACILLUS ACIDOPHILUS EXTRACT; LACTOBACILLUS BULGARICUS EXTRACT; LACTOBACILLUS CASEI EXTRACT; LACTOBACILLUS DELBRUECKII EXTRACT; LACTOBACILLUS EXTRACT; LACTOBACILLUS PLANTARUM EXTRACT; NATURAL PRODUCT; PROBIOTIC AGENT; SALMONELLA ABONI EXTRACT; STREPTOCOCCUS THERMOPHILUS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; BACTERIAL CELL WALL; BIFIDOBACTERIUM; CELL FRACTIONATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GASTROINTESTINAL MOTILITY; GUINEA PIG; ILEUM; IN VITRO STUDY; LACTOBACILLUS; MALE; NONHUMAN; REGULATORY MECHANISM; STREPTOCOCCUS;

EID: 33750237433     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i37.5987     Document Type: Article

References (31)

1. Fuller R. Probiotics in human medicine. Gut 1991; 32: 439-442
2. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519
3. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73: 430S-436S
4. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H, Weizman Z. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30: 54-60
5. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol 2000; 95: S16-S18
6. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randontized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001; 33 Suppl 2: S17-S25
7. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 2004; 38: 288-292
8. Wunderlich PF, Braun L, Fumagalli I, D'Apuzzo V, Heim F, Karly M, Lodi R, Politta G, Vonbank F, Zeltner L. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989; 17: 333-338
9. McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90: 439-448
10. Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163-169
11. de dios Pozo-Olano J, Warram JH Jr, Gomez RG, Cavazos MG. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial. Gastroenterology 1978; 74: 829-830
12. Katelaris PH, Salam I, Farthing MJ. Lactobacilli to prevent traveler's diarrhea? N Engl J Med 1995; 333: 1360-1361
13. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. J Travel Med 1997; 4: 41-43
14. Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996; 91: 1579-1585
15. Verdu EF, Collins SM. Irritable bowel syndrome and probiotics: from rationale to clinical use. Curr Opin Gastroenterol 2005; 21: 697-701
16. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1231-1238
17. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152: 735-741
18. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 895-904
19. Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103-1108
20. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354: 635-639
21. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309
22. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitah B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209
23. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-114
24. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela. T, Mattila-Sandholm T, von Wright A. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999; 65: 351-354
25. Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, Prins NH, Schuurkes JA. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 2001; 423: 71-83
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
27. Lammers KM, Brigidi P, Vitali B, Gionchetti P, Rizzello F, Caramelli E, Matteuzzi D, Campieri M. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003; 38: 165-172
28. Chiarini A, Budriesi R, Bolognesi ML, Minarini A, Melchiorre C. In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors. Br J Pharmacol 1995; 114: 1507-1517
29. Tallarida RJ, Murray RB. Manual of pharmacologic Calculations with Computer Programs. New York: Springer-Verlag, 1987
30. Motulsky H, Christopoulos A. Fitting Models to Biological Data Using Linear and Non Linear Regression. San Diego (CA): GraphPad Software Inc., 2003. Available from: http//www.graphpad.com
31. Motulsky H. Statistic Guide: Statistical Analysis for Laboratory and Clinical Research: A Pratical Guide to Curve Fitting. San Diego (CA): GraphPad Software Inc., 2003. Available from: http//www.graphpad.com